In this work, we investigate IFNγ-driven reprogramming of gene expression in tumour cells associated with acquired resistance to ICBT, therein demonstrating a role for the IFNγ target gene product poly-ADP ribosyl polymerase 14 (PARP14). This evidence concerns the gene PARP14 and neoplasm.